Imexpharm Corporation provided earnings guidance for the year 2018. For the year, the company expects total revenues of VND 1,400 billion, increase 18.1% compared 2017 and profit before tax & Technology and Science Development Fund of VND 190 billion, increase 16.9% compared 2017.